Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SunFire Biotechnologies
AddedFeb 16, 2024
UpdatedJun 18, 2026
SunFire Biotechnologies

SunFire Biotechnologies

SunFire Biotechnologies: A contract research organization specializing in vaccine evaluation.

HQ
Birmingham, AL, US
Overview
Compare
Fundraising
Employees
Website

SunFire Biotechnologies, founded by Dr. Moon Nahm, is a contract research organization focused on vaccine evaluation. The company's core mission is to support the development of vaccines through advanced immunological assays. Specializing in pneumococcal testing services and antibodies, SunFire Biotechnologies leverages proprietary technologies such as the WHO ELISA for antibodies against pneumococcal capsule and MOPA, which they invented. Their market focus includes pharmaceutical companies and research institutions involved in vaccine development.

Dr. Moon Nahm, a notable figure in immunology, leads the company, bringing significant expertise and innovation to the field. SunFire Biotechnologies has achieved recognition for its pioneering work in pneumococcal testing and antibody development. Their contributions have had a substantial impact on vaccine research, providing critical support to organizations aiming to combat infectious diseases. The company's advancements in immunological assays have positioned them as a key player in the biotechnological landscape.

SunFire Biotechnologies - Similar Companies

BiotechInnova logo

BiotechInnova

biotechinnova.com

Solaris Vaccines logo

Solaris Vaccines

solarisvax.com

Uvax Bio logo

Uvax Bio

uvaxbio.com

Moat Biotechnology logo

Moat Biotechnology

SunnyBay BioTech logo

SunnyBay BioTech

ImmunoProfile logo

ImmunoProfile

immunoprofile.com

BioAnalytics logo

BioAnalytics

Pamlico Biopharma logo

Pamlico Biopharma

Fluidigm logo

Fluidigm

standardbio.com

Idbiologics logo

Idbiologics

idbiologics.com

Epivax logo

Epivax

epivax.com

Great Lakes Biologics logo

Great Lakes Biologics

Taiga Biotechnologies logo

Taiga Biotechnologies

Sunflower Therapeutics logo

Sunflower Therapeutics

sunflowertx.com

Actinobac Biomed logo

Actinobac Biomed

SunFire Biotechnologies - Quick Facts

Who are SunFire Biotechnologies' competitors?

Companies similar to SunFire Biotechnologies include BiotechInnova, Solaris Vaccines, Uvax Bio and Moat Biotechnology.

Where is SunFire Biotechnologies' headquarters located?

SunFire Biotechnologies' headquarters is located in Birmingham, AL, US.

How much has SunFire Biotechnologies raised to-date?

As of Aug 30, 2022, SunFire Biotechnologies has raised a total of $1M (USD).

How many employees does SunFire Biotechnologies have?

SunFire Biotechnologies has 7 employees as of Feb 4, 2024.

SunFire Biotechnologies - Classification

Industry
  • Professional Service Companies
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Antibodies
  • Testing
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified